Vergoeding 2017-2021 voor ATC-subgroep L02BA : Anti-oestrogenen
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| L02BA01 Tamoxifen | 1.521.700 | 1.282.600 | 1.333.700 | 1.368.500 | 1.276.800 |
| L02BA03 Fulvestrant (Faslodex ®) | 6.868.200 | 8.474.600 | 9.012.600 | 9.145.600 | 7.648.000 |
| Totaal | 8.389.900 | 9.757.200 | 10.346.300 | 10.514.100 | 8.924.800 |